These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 28323900)

  • 1. Long-term exposure to estrogen enhances chemotherapeutic efficacy potentially through epigenetic mechanism in human breast cancer cells.
    Chang YW; Singh KP
    PLoS One; 2017; 12(3):e0174227. PubMed ID: 28323900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA demethylation by 5-aza-2-deoxycytidine treatment abrogates 17 beta-estradiol-induced cell growth and restores expression of DNA repair genes in human breast cancer cells.
    Singh KP; Treas J; Tyagi T; Gao W
    Cancer Lett; 2012 Mar; 316(1):62-9. PubMed ID: 22082530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly synergistic effect of sequential treatment with epigenetic and anticancer drugs to overcome drug resistance in breast cancer cells is mediated via activation of p21 gene expression leading to G2/M cycle arrest.
    Vijayaraghavalu S; Dermawan JK; Cheriyath V; Labhasetwar V
    Mol Pharm; 2013 Jan; 10(1):337-52. PubMed ID: 23215027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 5-azacytidine on miRNA expression in human breast cancer cells with different sensitivity to cytostatics.
    Chekhun VF; Borikun TV; Lukianova NY
    Exp Oncol; 2016 Mar; 38(1):26-30. PubMed ID: 27031715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer.
    Li Y; Meeran SM; Patel SN; Chen H; Hardy TM; Tollefsbol TO
    Mol Cancer; 2013 Feb; 12():9. PubMed ID: 23379261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetics and miRNA as predictive markers and targets for lung cancer chemotherapy.
    El-Awady RA; Hersi F; Al-Tunaiji H; Saleh EM; Abdel-Wahab AH; Al Homssi A; Suhail M; El-Serafi A; Al-Tel T
    Cancer Biol Ther; 2015; 16(7):1056-70. PubMed ID: 25962089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA demethylation increases sensitivity of neuroblastoma cells to chemotherapeutic drugs.
    Charlet J; Schnekenburger M; Brown KW; Diederich M
    Biochem Pharmacol; 2012 Apr; 83(7):858-65. PubMed ID: 22280814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of growth inhibition and epigenetic modulation by combination of green tea polyphenol and 5-aza-2'-deoxycytidine in human breast cancer cells.
    Tyagi T; Treas JN; Mahalingaiah PK; Singh KP
    Breast Cancer Res Treat; 2015 Feb; 149(3):655-68. PubMed ID: 25663548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanogel-mediated delivery of a cocktail of epigenetic drugs plus doxorubicin overcomes drug resistance in breast cancer cells.
    Vijayaraghavalu S; Labhasetwar V
    Drug Deliv Transl Res; 2018 Oct; 8(5):1289-1299. PubMed ID: 29947019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demethylating agent 5-aza-2-deoxycytidine enhances susceptibility of breast cancer cells to anticancer agents.
    Mirza S; Sharma G; Pandya P; Ralhan R
    Mol Cell Biochem; 2010 Sep; 342(1-2):101-9. PubMed ID: 20455010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global identification of genes regulated by estrogen signaling and demethylation in MCF-7 breast cancer cells.
    Putnik M; Zhao C; Gustafsson JÅ; Dahlman-Wright K
    Biochem Biophys Res Commun; 2012 Sep; 426(1):26-32. PubMed ID: 22902638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells.
    Li SY; Sun R; Wang HX; Shen S; Liu Y; Du XJ; Zhu YH; Jun W
    J Control Release; 2015 May; 205():7-14. PubMed ID: 25445694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic profiling of multidrug-resistant human MCF-7 breast adenocarcinoma cells reveals novel hyper- and hypomethylated targets.
    Chekhun VF; Lukyanova NY; Kovalchuk O; Tryndyak VP; Pogribny IP
    Mol Cancer Ther; 2007 Mar; 6(3):1089-98. PubMed ID: 17363502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mechanism for acquired cisplatin-resistance: suppressed translation of death-associated protein kinase mRNA is insensitive to 5-aza-2'-deoxycitidine and trichostatin in cisplatin-resistant cervical squamous cancer cells.
    Bai T; Tanaka T; Yukawa K; Umesaki N
    Int J Oncol; 2006 Feb; 28(2):497-508. PubMed ID: 16391806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer efficacy of cisplatin and trichostatin A or 5-aza-2'-deoxycytidine on ovarian cancer.
    Meng F; Sun G; Zhong M; Yu Y; Brewer MA
    Br J Cancer; 2013 Feb; 108(3):579-86. PubMed ID: 23370212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epigenetically regulated effects of Wnt antagonists on the expression of genes in the apoptosis pathway in human bladder cancer cell line (T24).
    Varol N; Konac E; Onen IH; Gurocak S; Alp E; Yilmaz A; Menevse S; Sozen S
    DNA Cell Biol; 2014 Jul; 33(7):408-17. PubMed ID: 24665856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suberoylanilide hydroxamic acid-induced specific epigenetic regulation controls Leptin-induced proliferation of breast cancer cell lines.
    Feng X; Han H; Zou D; Zhou J; Zhou W
    Oncotarget; 2017 Jan; 8(2):3364-3379. PubMed ID: 27926517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of epigenetic aberrations associated with the acquisition of doxorubicin resistance restores drug sensitivity in breast cancer cells.
    Ponnusamy L; Mahalingaiah PKS; Chang YW; Singh KP
    Eur J Pharm Sci; 2018 Oct; 123():56-69. PubMed ID: 30016648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic oxidative stress causes estrogen-independent aggressive phenotype, and epigenetic inactivation of estrogen receptor alpha in MCF-7 breast cancer cells.
    Mahalingaiah PK; Ponnusamy L; Singh KP
    Breast Cancer Res Treat; 2015 Aug; 153(1):41-56. PubMed ID: 26208486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The trefoil factor 1 (TFF1) protein involved in doxorubicin‑induced apoptosis resistance is upregulated by estrogen in breast cancer cells.
    Pelden S; Insawang T; Thuwajit C; Thuwajit P
    Oncol Rep; 2013 Sep; 30(3):1518-26. PubMed ID: 23836323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.